PPARGC1A and diabetes mellitus: Transgenic expression of PGC-1α or activation of PGC1-α in both experimental diabetic nephropathy and cultured podocytes decreased diabetes-induced podocytopenia and glomerular oxidative stress along with prevented mitochondrial dysfunction and cell death [68,73].